Gene editing trials on humans kickstart in U.S.
Devdiscourse News Desk | Philadelphia | Updated: 17-04-2019 22:49 IST | Created: 17-04-2019 22:37 IST
- Country:
- United States
The first human trials of the controversial gene editing technology called CRISPR, has officially started in the US.
Researchers at the University of Pennsylvania, are conducting a powerful experiment on cancer patients. As NPR reports, one patient had multiple myeloma and another one had sarcoma. Both the patients had relapsed after undergoing the standard treatment.
CRISPR is a technique in which modifications are made at the DNA level, with the potential to cure many diseases. A Chinese scientist, He Jiankui, used the technique to edit genes in human embryos that are now the world's first CRISPR twins.
(With inputs from agencies.)
Advertisement
ALSO READ
IAF airlifts to Srinagar two patients from Kargil needing urgent medical aid
Jay Shah welcomes 12,000 patients including those battling cancer, thalassemia to watch Titan's IPL match
WHO launches Patient Safety Rights Charter at Global Summit
BCCI hosts 12,000 cancer and thalassemia patients for Titans' IPL match
Comorbidities contribute to increased expenditure on drugs in elderly patients: Study